NCT04538859Recruiting
A Prospective Study of Factors Related to Exacerbation and Mortality of Non-cystic Fibrosis Bronchiectasis in Hong Kong
Source: ClinicalTrials.gov · Last updated 4 Sept 2020 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Bronchiectasis is associated with repeated exacerbations which occurs at rates of 1.5-6.5 per patients per year, and are associated with an increased risk of admission and readmission to hospital, and high health care costs. In a local study carried out more than 10 years ago, idiopathic disease dominates and patients with bronchiectasis are mainly female with high hospitalization and mortality rates; 21.9 cases per 100,000 and 2.7 cases per 100,000 respectively. Moreover, exacerbation characterized by increases in symptoms requiring antibiotic treatment is associated with disease progression and significant mortality. Updated prevalence of this disease with the characteristics of etiology, clinical presentation and outcomes are needed to guide further management plan.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 31 Aug 2020
- Start date
- 30 Aug 2020
- Primary completion date
- 29 Aug 2027
- Lead sponsor
- Chinese University of Hong Kong
- Diseases
- Cystic fibrosis
- NCT number
- NCT04538859
What you commit to
- Study type: Observational
- Planned participants: 400
- From 30 Aug 2020 to the primary completion date, 29 Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of cystic fibrosis; hypogammaglobulinemia; allergic bronchopulmonary aspergilosis
Other
- Those who are unable to give consent
Who the study is looking for
- Patients aged 18 years or older
- Clinically stable for at least 4 weeks prior to enrollment (defined as no symptoms of exacerbation, no requirement for supplemental antibiotic therapy)
- Diagnosis of bronchiectasis defined by high-resolution computed tomography scan
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chinese University of Hong Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.